:) Ja chápem, že vy mladí máte problém s čítaním s porozumením, ale ako sa hovorí, "Od tál, po tál" Uvádzam celé:
Citácia;LANCET, 4th of Sept. 2020 Safety and immunogenicity of an rAd26 and rAd5 vector-based heterologous prime boost COVID-19 vaccine in two formulations: two open, non-randomised phase 1/2 studies from Russia; Findings, first five sentences:
"Between June 18 and Aug 3, 2020, we enrolled 76 participants to the two studies (38 in each study). In each
study, nine volunteers received rAd26-S in phase 1, nine received rAd5-S in phase 1, and 20 received rAd26-S and
rAd5-S in phase 2. Both vaccine formulations were safe and well tolerated. The most common adverse events were
pain at injection site (44 [58%]), hyperthermia (38 [50%]), headache (32 [42%]), asthenia (21 [28%]), and muscle and
joint pain (18 [24%]). Most adverse events were mild and no serious adverse events were detected.,, "
